Adamas Pharmaceuticals (ADMS) PT Lowered to $23 at Piper Jaffray

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. KLAC
9. BIIB
10. PPG

Go back to Adamas Pharmaceuticals (ADMS) PT Lowered to $23 at Piper Jaffray

Needham & Company Downgrades Adamas Pharmaceuticals (ADMS) to Hold

March 5, 2019 7:35 AM EST

Needham & Company analyst Serge Belanger downgraded Adamas Pharmaceuticals (NASDAQ: ADMS) from Buy to Hold.

The analyst commented, "Gocovri ended 2018 with 4Q18 sales of $13.3MM (+25%Q/Q) via 5,730 fulfilled Rxs (+21%Q/Q) and was expected to double its market share to ~2% in... More

Mizuho Securities Downgrades Adamas Pharmaceuticals (ADMS) to Underperform

March 5, 2019 6:24 AM EST

Mizuho Securities analyst Irina Koffler downgraded Adamas Pharmaceuticals (NASDAQ: ADMS) from Neutral to Underperform with a price target of $5.00 (from $11.00) after guidance was withdrawn.

we believe the launch is likely going even worse than we thoughtWe now model $58.5M in 2019... More